Currently, Michael S. Hearne is Chief Financial Officer & Secretary at La Jolla Pharmaceutical Co. and Chief Financial Officer for Odonate Therapeutics, Inc.

Mr. Hearne previously occupied the position of Partner at Weaver & Tidwell LLP, Managing Director & Principal at Carson Private Capital, Inc. and Partner at Rothstein, Kass & Co. LLC.

Michael S. Hearne received an undergraduate degree from Brigham Young University and an undergraduate degree from Texas A&M University.